Skip to main content
Premium Trial:

Request an Annual Quote

People In The News: Jan 31, 2014

NEW YORK (GenomeWeb News) – AdvaMedDx announced this week that it has elected John Bishop as the new chair of its board of directors.

Bishop is chairman and CEO of Cepheid and has more than four decades of experience in leadership and executive management of medical device and diagnostics manufacturers. He joined Cepheid as CEO and director in April 2002. He has previously served as president, director, and CEO of Vysis; chairman and CEO of MicroProbe and Source Scientific Systems; and president and COO of Gen-Probe (now part of Hologic). In addition, he has served on the AdvaMedDx board since 2010.

Additionally, AdvaMedDx has newly elected to its board Robert Greczyn, interim president and CEO of LipoScience, for the 2014-2015 term.

Natera has appointed Herm Rosenman to be chief financial officer.

Rosenman has served on the genetic testing firm's board of directors since 2013. He most recently was senior VP of Finance and CFO of Gen-Probe, and before that he was president and CEO of Ultra Acquisition Corp. and of Radnet Management, a healthcare provider.

Metamark Genetics has named Jonathan Lieber senior VP and chief financial officer. Lieber formerly was CFO at Repligen Corporation, Xcellerex, and Atlus Pharmaceuticals.

At Atlus, he led a $10 million initial public offering. He also previously worked for a decade as an investment banker, where he executed a number of corporate financings, mergers, and acquisitions.

Kevin Shianna has left the New York Genome Center, where he was most recently deputy scientific director of sequencing operations.

His role has been taken over by Soren Germer and Dayna Oschwald, who both joined the NYGC in early 2012 as sequencing program managers.

Germer was previously a senior principal scientist at Roche Pharmaceuticals, where he led a genetics and next-gen sequencing lab. He holds a PhD from the University of California, Berkeley.

Oschwald came to the NYGC from Washington University School of Medicine, where she was the core manager of the Genome Technology Access Center.

Shianna joined the NYGC in mid-2012 and oversaw the creation of its pilot sequencing laboratory as well as its move to the NYGC's permanent location last year. It is not immediately clear where Shianna has taken up a new position.

Kapa Biosystems has made several hires to its management team. The reagents supplier has named Jean-Christophe Hatinguais to be director of international sales; Kobus Lindeque to be managing director of its facility in South Africa; Chris Tierney as director of business development; and Brian Komorous to be director of marketing.

Hatinguais, who will be responsible for PCR, qPCR, and next-generation sequencing product franchises, previously held executive posts at Qiagen, Applied Biosystems, and Waters.

Lindeque has spent 15 years at Monsanto and most recently was managing director for Monsanto Africa.

Tierney spent over 15 years in sales management at Thermo Fisher Scientific, Dharmacon, and Qiagen.

Komorous has over a decade of experience working at RainDance Technologies, Beckman Coulter Genomics, and BD Diagnostics.

Rockefeller University Professor David Allis has been awarded the Japan Prize, which carries with it a cash award of 50 million Japanese yen ($489,000).

Allis won the award for his discovery of how histone modifications are fundamental regulators of gene expression, which has heavily influenced the epigenetics field.

Bina Technologies, which is developing clinical analysis tools for whole-genome sequencing, has appointed Robert Green, Shashikant Kulkarni, Rong Chen, and Mark Gerstein to its scientific advisory board.

Green is an associate professor of medicine in the Division of Genetics at Brigham and Women's Hospital and Harvard Medical School. He is also associate director for research at the Partners HealthCare Center for Personalized Genetic Medicine.

Kulkarni is director of cytogenomics and molecular pathology, director of the Clinical Genomics Research Unit, and an associate professor of pediatrics, genetics, and pathology at the Washington University School of Medicine.

Chen is director of clinical genome informatics at the Icahn Institute of Genetics and Multiscale Biology.

Gerstein is the Albert Williams Professor of Biomedical Informatics, Molecular Biophysics & Biochemistry, and Computer Science at Yale University.

In addition, Bina has hired Janet Lankard as vice president of sales and Gianfranco de Feo as vice president of marketing.

Personalis has hired Deanna Church to the position of senior director of genomics and content. Church joined Personalis from the National Institutes of Health's National Center for Biotechnology Information, where she was a staff scientist for 12 years. She holds a PhD from the University of California, Irvine and a BA from the University of Virginia.

Personalis has also appointed Robert Nussbaum to its clinical and scientific advisory board. Nussbaum is a professor of medicine and chief of the division of genomic medicine at the University of California, San Francisco.

Randy Strube has recently been named director of global marketing for the Swiss 3D microtissue provider InSphero. Strube previously held posts at Enzo Life Sciences and Assay Designs, and has a technical background in 3D cell-based assays.

Leonard Loventhal
has resigned from Cellular Dynamics' board of directors, the company said in a filing with the US Securities and Exchange Commission this week

Loventhal served on the board's compensation committee and the nominating and governance committee.

The Genetics Society of America has named its 2014 Award Recipients, which include Frederick Ausubel; Angelika Amon; Hugo Bellen; Charles Boone; and Robin Wright.

Ausubel, of Harvard Medical School and Massachusetts General Hospital, won the Thomas Hunt Morgan Medal for a lifetime of contributions to the field of genetics. Amon, of the Massachusetts Institute of Technology and Howard Hughes Medical Institute, received a GSA award for outstanding contributions to genetics for the past 15 years. Bellen, of Baylor College of Medicine and HHMI, won the George W. Beadle Award for outstanding contributions to the community of genetics researchers. Boone, of the University of Toronto, received the Edward Novitski Prize, for extraordinary creativity and intellectual ingenuity in solving genetics research problems. And Wright, of the University of Minnesota, won the Elizabeth W. Jones Award for Excellence in Education.

Epic Sciences has tapped Michael Rodriguez to be company CFO. Rodriguez previously was COO at Clarient Diagnostic Services, where he led a group of more than 350 people in lab operations, IT, quality assurance, and other areas. He also formerly was senior VP and CFO at Endocare, executive VP and CFO of Directfit, and an executive at and EDiX Corporation.

Cambridge Isotope Laboratories said this week that it has hired Roswell Shelhamer as business development manager. Shelhamer previously held a sales position at Isotec, a division of Sigma-Aldrich.

The Center for Forensic DNA Analysis has appointed Sandra Close to be its chief science and technology officer. Close formerly held management posts at Eli Lilly, Caremark, and Baxter International, and she was CEO of GenEngine, a consulting firm advising biotechnology and pharmaceutical companies.

Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings